Subscribe
1-1-
Savushkin / iStockphoto.com
27 September 2017Africa

Interpol seizes 25m illicit and fake medicines

Interpol has seized more than $51 million worth of potentially dangerous medicines in its latest operation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Large-scale probe seizes 10.5m fake medicines
20 December 2022   Operation took place across Europe | Criminal networks are still exploiting opportunities offered by the COVID-19 pandemic.
Biotechnology
120 tons of counterfeit pesticides seized in Europe
6 July 2017   More than 120 tons of counterfeit pesticides have been seized during an operation by Europol.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Big Pharma
Large-scale probe seizes 10.5m fake medicines
20 December 2022   Operation took place across Europe | Criminal networks are still exploiting opportunities offered by the COVID-19 pandemic.
Biotechnology
120 tons of counterfeit pesticides seized in Europe
6 July 2017   More than 120 tons of counterfeit pesticides have been seized during an operation by Europol.

More on this story

Big Pharma
Large-scale probe seizes 10.5m fake medicines
20 December 2022   Operation took place across Europe | Criminal networks are still exploiting opportunities offered by the COVID-19 pandemic.
Biotechnology
120 tons of counterfeit pesticides seized in Europe
6 July 2017   More than 120 tons of counterfeit pesticides have been seized during an operation by Europol.

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims